KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Royalty Pharma (RPRX) Non Operating Investment Income (2019 - 2025)

Royalty Pharma (RPRX) has disclosed Non Operating Investment Income for 7 consecutive years, with -$1.0 million as the latest value for Q4 2025.

  • Quarterly Non Operating Investment Income rose 88.89% to -$1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$8.0 million through Sep 2025, down 366.67% year-over-year, with the annual reading at -$6.0 million for FY2024, 162.01% down from the prior year.
  • Non Operating Investment Income hit -$1.0 million in Q4 2025 for Royalty Pharma, down from $4.0 million in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $71.8 million in Q2 2022 to a low of -$17.0 million in Q3 2021.
  • Historically, Non Operating Investment Income has averaged $4.2 million across 5 years, with a median of -$990000.0 in 2022.
  • Biggest YoY gain for Non Operating Investment Income was 3861.39% in 2022; the steepest drop was 920.83% in 2022.
  • Year by year, Non Operating Investment Income stood at -$96000.0 in 2021, then crashed by 920.83% to -$980000.0 in 2022, then tumbled by 785.71% to -$8.7 million in 2023, then decreased by 3.69% to -$9.0 million in 2024, then soared by 88.89% to -$1.0 million in 2025.
  • Business Quant data shows Non Operating Investment Income for RPRX at -$1.0 million in Q4 2025, $4.0 million in Q3 2025, and -$2.0 million in Q2 2025.